Updated Jul 16, 2026
Santos da Silva Jorge has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $8.73M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | MLTX | MoonLake Immunotherapeutics | S — Open-market sale [10b5-1] | 68.3K | $20.02 | $1.37M |
| 2026-07-13 | MLTX | MoonLake Immunotherapeutics | S — Open-market sale [10b5-1] | 33.9K | $20.01 | $679K |
| 2026-07-02 | MLTX | MoonLake Immunotherapeutics | S — Open-market sale | 47.8K | $20.03 | $957K |
| 2026-04-14 | MLTX | MoonLake Immunotherapeutics | S — Open-market sale | 51.9K | $18.23 | $946K |
| 2026-04-14 | MLTX | MoonLake Immunotherapeutics | S — Open-market sale | 98.1K | $18.41 | $1.81M |
| 2025-12-22 | MLTX | MoonLake Immunotherapeutics | D — Derivative transaction | 196.3K | — | |
| 2025-12-22 | MLTX | MoonLake Immunotherapeutics | J — Other acquisition / disposition | 196.3K | — | |
| 2025-12-10 | MLTX | MoonLake Immunotherapeutics | S — Open-market sale | 70.0K | $14.49 | $1.01M |
| 2025-12-10 | MLTX | MoonLake Immunotherapeutics | S — Open-market sale | 130.0K | $15.08 | $1.96M |
Santos da Silva Jorge is a corporate insider — currently tracked as Chief Executive Officer, Director of MoonLake Immunotherapeutics (MLTX). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 7 open-market sales ($8.73M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Santos da Silva Jorge profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.